Authors:
Taner, CB
Severson, SR
Best, PJM
Lerman, A
Miller, VM
Citation: Cb. Taner et al., Treatment with endothelin-receptor antagonists increases NOS activity in hypercholesterolemia, J APP PHYSL, 90(3), 2001, pp. 816-820
Authors:
Wilson, SH
Simari, RD
Best, PJM
Peterson, TE
Lerman, LO
Aviram, M
Nath, KA
Holmes, DR
Lerman, A
Citation: Sh. Wilson et al., Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering, ART THROM V, 21(1), 2001, pp. 122-128
Authors:
Rodriguez-Porcel, M
Lerman, A
Best, PJM
Krier, JD
Napoli, C
Lerman, LO
Citation: M. Rodriguez-porcel et al., Hypercholesterolemia impairs myocardial perfusion and permeability: Role of oxidative stress and endogenous scavenging activity, J AM COL C, 37(2), 2001, pp. 608-615
Citation: Pjm. Best et Bj. Gersh, Cell adhesion molecules and inflammation in acute coronary syndromes: markers and emerging risk factors, EUR HEART J, 22(14), 2001, pp. 1155-1159
Authors:
Rodriguez-Porcel, M
Lerman, A
Ritman, EL
Wilson, SH
Best, PJM
Lerman, LO
Citation: M. Rodriguez-porcel et al., Altered myocardial microvascular 3D architecture in experimental hypercholesterolemia, CIRCULATION, 102(17), 2000, pp. 2028-2030
Authors:
Best, PJM
Lerman, LO
Romero, JC
Richardson, D
Holmes, DR
Lerman, A
Citation: Pjm. Best et al., Coronary endothelial function is preserved with chronic endothelin receptor antagonism in experimental hypercholesterolemia in vitro, ART THROM V, 19(11), 1999, pp. 2769-2775
Citation: Pjm. Best et al., The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators, PACE, 22(1), 1999, pp. 79-85
Authors:
Best, PJM
McKenna, CJ
Hasdai, D
Holmes, DR
Lerman, A
Citation: Pjm. Best et al., Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia, CIRCULATION, 99(13), 1999, pp. 1747-1752
Authors:
Wilson, SH
Best, PJM
Lerman, LO
Holmes, DR
Richardson, DM
Lerman, A
Citation: Sh. Wilson et al., Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF(2 alpha), in experimental hypercholesterolemia, CARDIO RES, 44(3), 1999, pp. 601-607